Bluejay DiagnosticsBJDX
13F holders, Q1 2025 (March 31)4holders +1
1new positions
0sold out
$3.73avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Bluejay Diagnostics Inc. (BJDX) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Tower Research Capital LLC (TRC) ($6K), UBS Group AG ($3K) and SBI Securities Co., Ltd. ($75).
- Company
- Bluejay Diagnostics Inc.
- CUSIP
- 095633509
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $75 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,205 shares bought and 1,133 shares sold, net +72 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Tower Research Capital LLC (TRC) | 0.00% | Add +213.9% | 1,739 | $6K |
| UBS Group AG | 0.00% | Reduce -58.3% | 812 | $3K |
| SBI Securities Co., Ltd. | 0.00% | New | 20 | $75 |
| Bank of America Corp. | 0.00% | No change | 4 | $15 |
"% of holder's portfolio" is BJDX's weight in each manager's 13F, not the share of Bluejay Diagnostics Inc. the manager owns.